Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Armstrong

Showing results (1011-1020 of 1,035) with videos related to

Pageof 104
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyDeborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Hereditary Cancer in Clinical Practice|March 18, 2015
Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United KingdomMark Harland, Anne E Cust, Celia Badenas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in OncologyRobert J Morgan, Deborah K Armstrong, Ronald D Alvarez, et al.
Journal of Medicinal Chemistry|December 22, 2025
Discovery of Bis-Acyl Hydrazides as Potent and Bioavailable MTA-Cooperative PRMT5 Inhibitors: A Case Study of Leveraging the Deuterium Kinetic Isotope EffectLaurent Debien, Megan K Armstrong, Joshua D Farr, et al.
Cancer Causes & Control : CCC|November 20, 2012
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortiumTodd M Gibson, Karin E Smedby, Christine F Skibola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2015
Development and validation of a melanoma risk score based on pooled data from 16 case-control studiesJohn R Davies, Yu-mei Chang, D Timothy Bishop, et al.
BMJ Open|June 23, 2020
Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in AustraliaEleonora Feletto, Jie-Bin Lew, Joachim Worthington, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Communications Medicine|May 23, 2022
Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growthKevin M Blum, Jacob C Zbinden, Abhay B Ramachandra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Pageof 104

Showing results (1011-1020 of 1,035) with videos related to

Sort By:
Pageof 104
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyDeborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Hereditary Cancer in Clinical Practice|March 18, 2015
Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United KingdomMark Harland, Anne E Cust, Celia Badenas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in OncologyRobert J Morgan, Deborah K Armstrong, Ronald D Alvarez, et al.
Journal of Medicinal Chemistry|December 22, 2025
Discovery of Bis-Acyl Hydrazides as Potent and Bioavailable MTA-Cooperative PRMT5 Inhibitors: A Case Study of Leveraging the Deuterium Kinetic Isotope EffectLaurent Debien, Megan K Armstrong, Joshua D Farr, et al.
Cancer Causes & Control : CCC|November 20, 2012
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortiumTodd M Gibson, Karin E Smedby, Christine F Skibola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2015
Development and validation of a melanoma risk score based on pooled data from 16 case-control studiesJohn R Davies, Yu-mei Chang, D Timothy Bishop, et al.
BMJ Open|June 23, 2020
Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in AustraliaEleonora Feletto, Jie-Bin Lew, Joachim Worthington, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Communications Medicine|May 23, 2022
Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growthKevin M Blum, Jacob C Zbinden, Abhay B Ramachandra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Pageof 104